← Open Payments lookup

EMILY MILLER: Open Payments

NPI 1407239569 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,083 in 61 payments from 15 companies in 2025. Trend: 2023 $732 · 2024 $923 · 2025 $1,083

Food & beverage: $1,083
CompanyPaymentsAmount
ABBVIE INC.24$397
Novo Nordisk Inc11$174
Neos Therapeutics, LP3$64
Corcept Therapeutics3$60
Axsome Therapeutics, Inc.2$56
Amneal Pharmaceuticals LLC2$55
Amgen Inc.3$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$41
Astellas Pharma US Inc2$35
Abbott Laboratories2$34

Products named: VRAYLAR, UBRELVY, Ozempic, Wegovy, Adzenys XR-ODT, Korlym, Auvelity, UNITHROID.

Industry payments across IN — which companies pay providers there.